Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Section Head, JHB Psychiatry Substance Abuse Programs, Medical Director, Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Director, C
Psychiatry
Dr. Eric C. Strain, MD
|
|
Give Review
Eric Strain practices Psychiatry. He went to The Ohio State University College of Medicine. He has 2 awards "America's Top Doctors" and "Top Doctors:Baltimore Area". Eric Strain is a published physician. He published 99 publications, including: 'Induction with levomethadyl acetate: safety and efficacy.' He is registered with Medicare and accepts Medicare payments.
Publications
- A randomized controlled trial of the effects of working memory training in methadone maintenance patients.
- Characterizing Pain and associated coping strategies in methadone and buprenorphine-maintained patients.
- Effects of methadone plus Alcohol on cognitive performance in methadone-maintained volunteers.
- Behavioural health interventions in the Johns Hopkins Community Health Partnership: integrated care as a component of health systems transformation.
- Sources of nonmedically used prescription stimulants: Differences in onset, recency and severity of misuse in a population-based study.
- Introduction to CPDD abstracts.
- Patterns of concurrent substance use among nonmedical ADHD stimulant users: Results from the National Survey on Drug Use and Health.
- Topiramate for cocaine Dependence during methadone maintenance treatment: A randomized controlled trial.
- Methadone safety: a clinical practice guideline from the american pain society and college on problems of drug Dependence, in collaboration with the heart rhythm society.
- A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.
- Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.
- Opioid Abusers' ability to differentiate an opioid from placebo in laboratory challenge testing.
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence.
- Word reading in Alzheimer''s disease: cross-sectional and longitudinal analyses of response time and accuracy data.
- Imageability effects in word naming: an individual differences analysis.
- The behavioral pharmacology of Alcohol and other drugs. Emerging issues.
- Intravenous drug abusers with antisocial personality Disorder: high rate of HIV-1 infection.
- Antisocial personality Disorder, misbehavior, and drug abuse.
- Caffeine Dependence: fact or fiction?
- Intravenous drug abusers with antisocial personality Disorder: increased HIV risk behavior.
- Psychosocial treatments for cocaine Dependence: rethinking lessons learned.
- Caffeine dependence syndrome. Evidence from case histories and experiMental evaluations.
- Withdrawal syndrome after the double-blind cessation of caffeine consumption.
- Effects of cocaine alone and in Combination with bromocriptine in human cocaine abusers.
- Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films.
- The effects of buprenorphine in methadone-dependent volunteers.
- Early treatment time course of Depressive symptoms in opiate addicts.
- Dose-response effects of methadone in the treatment of opioid Dependence.
- Buprenorphine versus methadone in the treatment of opioid Dependence: self-reports, urinalysis, and addiction severity index.
- Opioid antagonist effects of dezocine in opioid-dependent humans.
- Dose-related efficacy of levomethadyl acetate for treatment of opioid Dependence. A randomized clinical trial.
- Moderate- vs high-dose methadone in the treatment of opioid Dependence: a randomized trial.
- Induction with levomethadyl acetate: safety and efficacy.
- Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
- Effects of buprenorphine/naloxone in opioid-dependent humans.
- A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid Dependence.
- Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid Abusers.
- Enhancement of cocaine''s Abuse liability in methadone maintenance patients.
- Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
- The effects of buprenorphine in buprenorphine-maintained volunteers.
- Buprenorphine treatment of opioid Dependence: clinical trial of daily versus alternate-day dosing.
- A placebo controlled clinical trial of buprenorphine as a treatment for opioid Dependence.
- Methadone dose and treatment outcome.
- The triply diagnosed: patients with major Mental illness, cognitive impairment, and substance abuse.
- Comparison of buprenorphine and methadone in the treatment of opioid Dependence.
- Outcome after methadone treatment: influence of prior treatment factors and current treatment status.
- Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
- Buprenorphine versus methadone in the treatment of opioid-dependent Cocaine users.
- Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
- Clustering of multiple substance use and psychiatric diagnoses in opiate addicts.
- Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
- Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
- Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
- Enadoline and butorphanol: evaluation of kappa-agonists on Cocaine pharmacodynamics and Cocaine self-administration in humans.
- Gradual dose taper following chronic buprenorphine.
- The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.
- Discriminative stimulus effects of tramadol in humans.
- Increased blood pressure after abrupt cessation of daily cannabis use.
- Drug use and sport--a commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al.
- A randomized controlled trial of fluoxetine in the treatment of cocaine Dependence among methadone-maintained patients.
- Changes at drug and Alcohol dependence.
- Effects of oral caffeine pretreatment on response to intravenous nicotine and Cocaine.
- Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance Abuse treatment center.
- Physical Dependence potential of daily tramadol dosing in humans.
- Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid Abusers.
- Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.
- Human Abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.
- The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance Abuse.
- Relationship between cigarette use and mood/anxiety Disorders among pregnant methadone-maintained patients.
- Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawa...
- Changing profile of Abused substances by older persons entering treatment.
- Caffeinated energy drinks--a growing problem.
- ExperiMentally-induced spontaneous opiate withdrawal: relationship to cigarette craving and expired air carbon monoxide.
- Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
- Treatment of patients with substance use Disorders, second edition. American Psychiatric Association.
- Buprenorphine for postoperative Pain following general surgery in a buprenorphine-maintained patient.
- Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
- Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a res...
- Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass ...
- Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
- Treatment of patients with substance use Disorders, second edition. American Psychiatic Association.
- HIV risk behaviors during pharmacologic treatment for opioid Dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
- Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
- Impact of formulation on the Abuse liability, safety and regulation of medications: the expert panel report.
- Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid Dependence.
- Decreased frontal white-matter volume in chronic substance Abuse.
- Characteristics of older opioid maintenance patients.
- Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine Dependence: a randomized clinical trial.
- [Brazilian guideline for the treatment of patients with opioids Dependence syndrome].
- A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
- Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.
- Buprenorphine: how to use it right.
- Single versus multiple Drug focus in substance abuse clinical trials research: the devil is in the details.
- Review: there is insufficient evidence for naltrexone maintenance treatment in opioid Dependence.
- Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
- Assessment and treatment of comorbid psychiatric Disorders in opioid-dependent patients.
- A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformula...
Schools
Ohio State University College of Medicine
Johns Hopkins Hospital
Procedures Preformed
- Group Psychotherapy
Conditions Treated
- Adjustment Disorder
- Alcohol-Induced Mental Disorders
- Alcoholism (Alcohol Dependence)
- Anxiety
- View All
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Baltimore Area
Education
-
Johns Hopkins University -
The Ohio State University College of Medicine
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1154356038 | |
| NPPES Provider LastName | STRAIN | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 212242735 | |
| NPPES Provider State | MD | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 211.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154356038 |
| Last Name Of The Provider | STRAIN |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Moira U. Bogrov, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna M. Gonzaga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Lion, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph G. Liberto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Norris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Weintraub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tanya S. Khazan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth R. Tomar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adela Valadez Meltzer, MD |
|
|
Dr. Charles R. Arthur III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren V. Moran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul E. Roberts, MD |
|
|
Dr. Priscilla W. Sheldon-Cost, MD
This Doctor is OpenDoctor Recommended.
|